Investigating how estrogen receptor variants affect inflammation in autoimmune diseases.
The Role of Estrogen Receptor Alpha Variant Size and Localization in Modulating TLR7-Induced Inflammation
This study is looking at how different types of estrogen receptors might affect inflammation in women with lupus, hoping to find new ways to understand and treat this autoimmune disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11009003 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of estrogen receptor alpha variants in modulating inflammation related to autoimmune diseases, particularly systemic lupus erythematosus (SLE), which predominantly affects females. The study aims to explore how different forms of this receptor influence immune responses and disease progression. By using animal models, the researchers will examine the protective effects of a specific short form of the estrogen receptor and its impact on inflammation triggered by Toll-like receptors. This could lead to new insights into how sex hormones contribute to autoimmune conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are females diagnosed with systemic lupus erythematosus or other autoimmune diseases.
Not a fit: Patients with autoimmune diseases not related to estrogen receptor activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for autoimmune diseases, particularly for women affected by conditions like lupus.
How similar studies have performed: Previous research has shown promising results regarding the role of estrogen receptors in autoimmune diseases, suggesting that this approach could yield significant insights.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Cunningham, Melissa a — Medical University of South Carolina
- Study coordinator: Cunningham, Melissa a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.